Article Details

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Brokerages

Retrieved on: 2022-12-31 11:41:09

Tags for this article:

Click the tags to see associated articles and topics

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Brokerages. View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-nvax-consensus-analyst-rating-2022-12-2-3/

Excerpt

Vanguard Group Inc. now owns 7,495,924 shares of the biopharmaceutical company's stock worth $136,426,000 after acquiring an additional 144,999 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up